Sotera Health Company reported a significant increase in financial performance for the second quarter of 2026, with total net revenues reaching $321.4 million, a 9.2% increase from $294.3 million in the same period last year. For the first half of 2026, revenues totaled $601.4 million, up 9.6% from $548.9 million in the first half of 2025. The company achieved a net income of $53.6 million for the second quarter, compared to $8.0 million in the prior year, and a net income of $80.2 million for the first half, a substantial recovery from a net loss of $5.3 million in the same period last year.
The growth in revenue was driven by an increase in service revenues, which rose by 8.2% to $278.3 million, and product revenues, which increased by 16.0% to $43.1 million. The Sterigenics segment, which provides sterilization services, contributed significantly to this growth, with revenues of $211.6 million, an 8.6% increase year-over-year. The Nordion segment, focused on Co-60 supply, saw a 15.8% increase in revenues to $49.1 million, attributed to favorable pricing and timing of reactor harvest schedules.
Operationally, Sotera Health has made strategic investments, with capital expenditures amounting to $92.6 million in the first half of 2026, compared to $51.1 million in the same period of 2025. The company also reported a cash balance of $356.7 million as of June 30, 2026, reflecting a $10.3 million increase from the end of 2025. The total employee headcount has remained stable, supporting the company's operational capabilities across its three segments: Sterigenics, Nordion, and Nelson Labs.
Looking ahead, Sotera Health anticipates continued growth driven by favorable market conditions and strategic initiatives. The company is focused on expanding its sterilization and lab services, while also managing costs effectively. However, it remains cautious about potential risks, including supply chain disruptions and ongoing litigation related to ethylene oxide emissions. The company’s management has expressed confidence in its ability to navigate these challenges while maintaining its commitment to safeguarding global health through its essential services.
About Sotera Health Co
Sotera Health is a global provider of sterilization solutions, lab testing, and advisory services for the healthcare industry. Its core activities include outsourced sterilization using gamma, ethylene oxide, and electron beam technologies, as well as microbiological and analytical testing through Nelson Labs. Serving medical device, pharmaceutical, and food markets, the company ensures product safety, regulatory compliance, and supply chain integrity worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov